Emerald Mutual Fund Advisers Trust’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-474,433	Closed	-$24.8M	–	239
2018 Q3	$24.8M	Buy	474,433 +122,380	+35%	+$6.67M	0.84%	31
2018 Q2	$15.3M	Sell	352,053 -237,702	-40%	-$10.2M	0.55%	65
2018 Q1	$21.9M	Buy	589,755 +8,898	+2%	+$237K	0.86%	29
2017 Q4	$11.5M	Buy	580,857 +2,800	+0.5%	+$60.2K	0.46%	76
2017 Q3	$14.4M	Hold	578,057	–	–	0.6%	59
2017 Q2	$10.1M	Buy	+578,057	New	+$10.1M	0.44%	80

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's GTHX Position: Q4 2018 in Review

Emerald Mutual Fund Advisers Trust sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2018, closing a stake of 474,433 shares — an estimated $24.8M sold.

Emerald Mutual Fund Advisers Trust first reported a position in GTHX in Q2 2017 and held it in 6 quarters. The position peaked at $24.8M in Q3 2018. 93 funds tracked by Wall St. Rank hold GTHX as of Q4 2018.

Emerald Mutual Fund Advisers Trust reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 474,433 G1 Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $24.8M.
Emerald Mutual Fund Advisers Trust first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 6 quarters.
Emerald Mutual Fund Advisers Trust's G1 Therapeutics, Inc. Common Stock position peaked at $24.8M in Q3 2018.
93 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2018, filed 30 Jan 2019.